| Type | Valeur |
|---|---|
| cik | 0000319240 |
| ticker | IRI |
| Date | Type | Insider | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 31 oct. 2012 | TENDER | Wasserman Stephen Edward | 28 534 | 19.50 USD | |
| 31 oct. 2012 | EXERCISE | Wasserman Stephen Edward | 10 000 | 15.26 USD | |
| 31 oct. 2012 | EXERCISE | Wasserman Stephen Edward | 13 043 | 16.89 USD | |
| 31 oct. 2012 | SALE | Wasserman Stephen Edward | 16 482 | 19.50 USD | |
| 31 oct. 2012 | EXERCISE | Wasserman Stephen Edward | 12 541 | 11.61 USD | |
| 31 oct. 2012 | EXERCISE | Wasserman Stephen Edward | 2 414 | 13.26 USD | |
| 31 oct. 2012 | TAX_WITHHOLDING | Wasserman Stephen Edward | 35 404 | 19.50 USD | |
| 31 oct. 2012 | EXERCISE | Wasserman Stephen Edward | 13 888 | 10.07 USD | |
| 31 oct. 2012 | EXERCISE | Wasserman Stephen Edward | 10 000 | 0.00 USD | deriv |
| 31 oct. 2012 | EXERCISE | Wasserman Stephen Edward | 13 043 | 0.00 USD | deriv |
| 31 oct. 2012 | EXERCISE | Wasserman Stephen Edward | 13 888 | 0.00 USD | deriv |
| 31 oct. 2012 | OTHER | Wasserman Stephen Edward | 2 828 | 19.50 USD | deriv |
| 31 oct. 2012 | EXERCISE | Wasserman Stephen Edward | 2 414 | 0.00 USD | deriv |
| 31 oct. 2012 | OTHER | Wasserman Stephen Edward | 7 245 | 6.24 USD | deriv |
| 31 oct. 2012 | EXERCISE | Wasserman Stephen Edward | 12 541 | 0.00 USD | deriv |
| 31 oct. 2012 | EXERCISE | VOBORIL EDWARD F | 13 888 | 10.07 USD | |
| 31 oct. 2012 | TENDER | VOBORIL EDWARD F | 30 896 | 19.50 USD | |
| 31 oct. 2012 | EXERCISE | VOBORIL EDWARD F | 12 931 | 16.86 USD | |
| 31 oct. 2012 | EXERCISE | VOBORIL EDWARD F | 11 853 | 16.86 USD | |
| 31 oct. 2012 | SALE | VOBORIL EDWARD F | 15 918 | 19.50 USD | |
| 31 oct. 2012 | EXERCISE | VOBORIL EDWARD F | 12 541 | 11.61 USD | |
| 31 oct. 2012 | EXERCISE | VOBORIL EDWARD F | 2 414 | 13.26 USD | |
| 31 oct. 2012 | TAX_WITHHOLDING | VOBORIL EDWARD F | 37 709 | 19.50 USD | |
| 31 oct. 2012 | EXERCISE | VOBORIL EDWARD F | 13 888 | 0.00 USD | deriv |
| 31 oct. 2012 | EXERCISE | VOBORIL EDWARD F | 11 853 | 0.00 USD | deriv |